catalyst

MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunct — primary completion

as of 2026-07-01
at a glance
2027-01-31 · Estimated (est.)Registry-estimated date, not yet actual.
Synthesized from structured facts only — each point cited above.

Event

What
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunct — primary completion
Type
Trial Readout
Date
2027-01-31
Date type
ESTIMATED est.
Phase
Phase 2,PHASE3
Registry-estimated date, not yet actual. This date is directional and must not be read as settled.